New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system.

Suppr

超能文献

作者信息

Uetrecht J P

机构信息

Faculties of Pharmacy and Medicine, University of Toronto, Toronto, Ontario, Canada M5S 2S2.

出版信息

Chem Res Toxicol. 1999 May;12(5):387-95. doi: 10.1021/tx980249i.

DOI:10.1021/tx980249i

PMID:10328748

Abstract

摘要

相似文献

New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system.

Chem Res Toxicol. 1999 May;12(5):387-95. doi: 10.1021/tx980249i.

The danger hypothesis--potential role in idiosyncratic drug reactions.危险假说——在特异质药物反应中的潜在作用

Toxicology. 2002 Dec 27;181-182:55-63. doi: 10.1016/s0300-483x(02)00255-x.

Role of drug metabolism for breaking tolerance and the localization of drug hypersensitivity.药物代谢在打破耐受性及药物超敏反应定位中的作用。

Toxicology. 2005 Apr 15;209(2):113-8. doi: 10.1016/j.tox.2004.12.019. Epub 2005 Jan 26.

The danger hypothesis applied to idiosyncratic drug reactions.应用于特异质药物反应的危险假说。

Handb Exp Pharmacol. 2010(196):493-509. doi: 10.1007/978-3-642-00663-0_18.

Prediction of a new drug's potential to cause idiosyncratic reactions.预测一种新药引发特异反应的可能性。

Curr Opin Drug Discov Devel. 2001 Jan;4(1):55-9.

Adverse drug reactions: types and treatment options.药物不良反应：类型及治疗选择

Am Fam Physician. 2003 Nov 1;68(9):1781-90.

The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity.药物代谢在T细胞介导的药物超敏反应发病机制中的作用。

Curr Opin Allergy Clin Immunol. 2008 Aug;8(4):299-307. doi: 10.1097/ACI.0b013e3283079c64.

Animal models of idiosyncratic drug reactions.特异质药物反应的动物模型

Chem Biol Interact. 2004 Nov 1;150(1):53-70. doi: 10.1016/j.cbi.2004.09.001.

[Pharmacologic and biologic basis of drug allergies].[药物过敏的药理和生物学基础]

Therapie. 2000 Jan-Feb;55(1):7-12.

Tolerogenic role of Kupffer cells in immune-mediated adverse drug reactions.库普弗细胞在免疫介导的药物不良反应中的耐受原性作用。

Toxicology. 2005 Apr 15;209(2):109-12. doi: 10.1016/j.tox.2004.12.017.

引用本文的文献

TAK-994 mechanistic investigation into drug-induced liver injury.TAK-994药物性肝损伤的机制研究

Toxicol Sci. 2025 Apr 1;204(2):143-153. doi: 10.1093/toxsci/kfaf003.

Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.药物在人类肝脏中的分子特异性毒理学与动物比较：基本考虑因素。

Int J Mol Sci. 2023 Apr 3;24(7):6663. doi: 10.3390/ijms24076663.

Treatment of Drug-Induced Liver Injury.药物性肝损伤的治疗

Biomedicines. 2022 Dec 21;11(1):15. doi: 10.3390/biomedicines11010015.

Idiosyncratic Drug Reactions: A 35-Year Perspective.药物特异质反应：35 年的观察

Chem Res Toxicol. 2022 Oct 17;35(10):1649-1654. doi: 10.1021/acs.chemrestox.2c00090. Epub 2022 Jun 10.

Drug-Induced Idiosyncratic Agranulocytosis - Infrequent but Dangerous.药物性特发性粒细胞缺乏症——虽不常见但危险。

Front Pharmacol. 2021 Aug 13;12:727717. doi: 10.3389/fphar.2021.727717. eCollection 2021.

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.特异质性药物性肝损伤（DILI）的机制：尚未解决的基本问题。

Ann Transl Med. 2021 Apr;9(8):730. doi: 10.21037/atm-2020-ubih-05.

Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies.特发性药物性肝损伤、细胞色素 P450、代谢风险因素和脂溶性：要点和争议。

Int J Mol Sci. 2021 Mar 26;22(7):3441. doi: 10.3390/ijms22073441.

Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges.特发性药物性肝损伤：机制和临床挑战。

Int J Mol Sci. 2021 Mar 14;22(6):2954. doi: 10.3390/ijms22062954.

Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity.药物性肝损伤的生物标志物：通过对乙酰氨基酚肝毒性的机制观点。

Expert Rev Gastroenterol Hepatol. 2021 Apr;15(4):363-375. doi: 10.1080/17474124.2021.1857238. Epub 2020 Dec 9.

Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications.细胞色素P450内质网相关降解（ERAD）：治疗学和病理生理学意义

Acta Pharm Sin B. 2020 Jan;10(1):42-60. doi: 10.1016/j.apsb.2019.11.002. Epub 2019 Nov 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验